Literature DB >> 3689000

Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications.

A J Geirsson1, G Sturfelt, L Truedsson.   

Abstract

Sixteen patients with classic rheumatoid arthritis (RA) complicated by severe vasculitis were studied and compared with a matched control group of 16 RA patients without vasculitis. Seven of the patients with vasculitis died within 4 to 120 months (median 32 months) after developing vasculitic symptoms. Gangrene of digits and extremities, bowel ulcers or bowel perforation, or both, and cardiac involvement were more common among the patients who died than among those with a more favourable course. The present data suggest that large vessel vasculitis in RA is associated with high frequency of arteriosclerotic vascular disease. The serum concentrations of complement components C3 and C4 were lower, and concentrations of IgM rheumatoid factor, complement activating rheumatoid factor, and C1q binding immune complexes (C1q solid and C1q fluid phase assay) were significantly higher among vasculitic patients than in the control group. Laboratory data provided little prognostic information with regard to rheumatoid vasculitis, with the exception that IgM and IgG rheumatoid factors were significantly higher among patients with fatal course of disease than in those who achieved remission.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3689000      PMCID: PMC1003378          DOI: 10.1136/ard.46.10.727

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  25 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  ARA NOMENCLATURE AND CLASSIFICATION OF ARTHRITIS AND RHEUMATISM (TENTATIVE).

Authors:  B S BLUMBERG; J J BUNIM; E CALKINS; C L PIRANI; N J ZVAIFLER
Journal:  Arthritis Rheum       Date:  1964-02

3.  Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases.

Authors:  D G Scott; P A Bacon; C R Tribe
Journal:  Medicine (Baltimore)       Date:  1981-07       Impact factor: 1.889

4.  Clinical background of rheumatoid vascular disease.

Authors:  M Wilkinson; W N Torrance
Journal:  Ann Rheum Dis       Date:  1967-11       Impact factor: 19.103

5.  Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.

Authors:  R H Zubler; G Lange; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

6.  IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.

Authors:  D G Scott; P A Bacon; C Allen; C J Elson; T Wallington
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

7.  Double-decker rocket immunoelectrophoresis for direct quantitation of complement C3 split products with C3d specificities in plasma.

Authors:  I Brandslund; H C Siersted; S E Svehag; B Teisner
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

8.  International reference preparation of rheumatoid arthritis serum.

Authors:  S G Anderson; M W Bentzon; V Houba; P Krag
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

9.  Rheumatoid vasculitis: effect of cyclophosphamide on the clinical course and levels of circulating immune complexes.

Authors:  T Abel; B S Andrews; P H Cunningham; C M Brunner; J S Davis; D A Horwitz
Journal:  Ann Intern Med       Date:  1980-09       Impact factor: 25.391

10.  C1 activation, with C1q in excess of functional C1 in synovial fluid from patients with rheumatoid arthritis.

Authors:  A G Sjöholm; K Berglund; U Johnson; A B Laurell; G Sturfelt
Journal:  Int Arch Allergy Appl Immunol       Date:  1986
View more
  16 in total

Review 1.  Complement in the immunopathogenesis of rheumatic disease.

Authors:  Gunnar Sturfelt; Lennart Truedsson
Journal:  Nat Rev Rheumatol       Date:  2012-06-05       Impact factor: 20.543

Review 2.  Prognostic factors of severe rheumatoid arthritis.

Authors:  R Westhovens
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

3.  Vasculitis associated with rheumatoid arthritis: a case-control study.

Authors:  Ashima Makol; Cynthia S Crowson; David A Wetter; Olayemi Sokumbi; Eric L Matteson; Kenneth J Warrington
Journal:  Rheumatology (Oxford)       Date:  2014-01-17       Impact factor: 7.580

4.  Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis.

Authors:  C Turesson; L T H Jacobsson; G Sturfelt; E L Matteson; L Mathsson; J Rönnelid
Journal:  Ann Rheum Dis       Date:  2006-08-10       Impact factor: 19.103

5.  Increased levels of rheumatoid factors after TNF inhibitor in rheumatoid arthritis.

Authors:  José Alexandre Mendonça; João Francisco Marques-Neto; Adil Muhib Samara; Simone Appenzeller
Journal:  Rheumatol Int       Date:  2011-02-15       Impact factor: 2.631

Review 6.  Gastrointestinal Perforations with Biologics in Patients with Rheumatoid Arthritis: Implications for Clinicians.

Authors:  Aprajita Jagpal; Jeffrey R Curtis
Journal:  Drug Saf       Date:  2018-06       Impact factor: 5.606

Review 7.  B lymphocytes and humoral immune responses in rheumatoid arthritis.

Authors:  L S De Clerck
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

8.  Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years.

Authors:  C Turesson; W M O'Fallon; C S Crowson; S E Gabriel; E L Matteson
Journal:  Ann Rheum Dis       Date:  2003-08       Impact factor: 19.103

9.  Detection of cytomegalovirus antigens in phagocytosed serum complexes from a patient with rheumatoid arthritis, vasculitis, peripheral neuropathy, cutaneous ulceration, and digital gangrene.

Authors:  J N McCormick; D Wojtacha; E Edmond
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

Review 10.  Overview of vasculitis and vasculopathy in rheumatoid arthritis--something to think about.

Authors:  Mislav Radic; Dusanka Martinovic Kaliterna; Josipa Radic
Journal:  Clin Rheumatol       Date:  2013-05-07       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.